Combining chemotherapy and BRAF oncogene inhibitors is a very effective strategy for fighting metastatic melanoma, the leading cause of death from skin cancer in the world.
Read moreAlejo Efeyan's team at the CNIO has shown in animal models that blocking signals controlled by the RagC protein delays the onset of follicular lymphoma without side effects
Read moreResearchers from IDIBAPS, IBEC, UB and CIBERES discover how force dynamics affect cells and living tissues. The results give an insight into the critical mechanical processes that occur in different d...
Read moreA study in which IrsiCaixa has participated shows that the anticancer drug dasatinib, in combination with antiretroviral treatment, reduces the reactivation ability and the size of the viral reservoir...
Read moreLa simple exposición al VIH, sin necesidad que se produzca infección por el virus, altera el nivel de algunos biomarcadores inmunitarios en niños. Así lo demuestra un estudio desarrollado por i...
Read moreKRAS was one of the first oncogenes to be identified, a few decades ago. It is among the most common drivers of cancer and its mutations can be detected in around 25 per cent of human tumours. The dev...
Read moreResearchers at IRB Barcelona unveil a pathway that determines the fate of cells in response to stress conditions and identify an important mechanism that recovers cell balance.
Read moreLiderado por la investigadora Sònia Guedan, el proyecto se basa en el desarrollo de la inmunoterapia para atacar los tumores sólidos
Read moreGracias al apoyo de la Fundación, Alejo Efeyan liderará el proyecto NUTRITHELIUM, que busca el origen de las patologías asociadas a la obesidad y cómo combatirlas Dotado con cerca de 1
Read moreEight researches led by or with the participation of scientists from the Spanish National Research Council (CSIC) have been selected by the “la Caixa” Foundation among the 30 projects of the Caixa...
Read moreThe Genetics of Malignant Hemopathies research group at ibs.GRANADA has shown that certain variations in genes of the immune system influence the risk of developing acute myeloid leukemia. These alter...
Read moreThe study suggests that tumors with a genetically inactivated form of the chromatin remodeling protein SMARCA4 are highly sensitive to inhibitors of the KDM6 family of histone demethylases.
Read more